Loading XELPMOC price...
Peers are the listed companies in the exchange's own industry group: Software Products. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales rose 22.5% from a year earlier to Rs 1.0 cr and the loss was Rs 2.2 cr against Rs 1.9 cr a year earlier.
- No borrowings at the FY26 balance sheet.
- Sales fell 3 years running (Rs 14.7 cr in FY23 to Rs 3.7 cr in FY26).
- Reported a loss in FY24 and FY25 and FY26.
- Operating margin fell from -108.2% in FY23 to -194.6% in FY26.
- Return on equity stayed under 10% from FY24 to FY26 (highest -10.2%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 20 results, the share rose on 4 and fell on 16, and moved by 3% or more on 10.
Q1 FY27: results filed 14 Aug 2026. The share went from its close on 13 Aug 2026 to its close on 17 Aug 2026 -1.91%.
Of every Rs 100 of sales in FY26, Rs 295 went on running costs, Rs 27 on depreciation; the year ended in a loss.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | 81.5% | -55.8% | -40.0% | -5.1% |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | -180% | -108% | -180% | -190% | -195% |
| Net marginProfit after everything, per Rs 100 of sales. | -158% | -109% | -214% | -231% | -205% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | -23.7% | -22.4% | -14.0% | -10.2% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | - | -21.3% | -18.8% | -11.3% | -9.2% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | - | 0.00x | 0.00x | 0.00x | 0.00x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | - | -53.0x | -66.5x | -89.0x | - |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 86 Cr of assets. Its owners funded 87% of that, with no borrowings.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -6 Cr, spent Rs 1 Cr on plant and equipment, and cash rose by Rs 0 Cr over the year.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| OFSS Oracle Financial Services Software Limited | 86,441 cr | 24.3x | 11.2x | 46.4% | - | 0.00 | 39.4% | +6.6% | 3.97% |
| TANLA Tanla Platforms Limited | 7,530 cr | 14.1x | 3.0x | 21.4% | 25.2% | 0.00 | 11.6% | +17.9% | 2.13% |
| MAPMYINDIA C.E. Info Systems Limited | 4,530 cr | 33.1x | 5.0x | 15.2% | 21.4% | 0.00 | 28.0% | +14.9% | 0.42% |
| CAPILLARY Capillary Technologies India Limited | 4,433 cr | - | 4.3x | - | 5.4% | 0.04 | - | - | 0.00% |
| RAMCOSYS Ramco Systems Limited | 1,909 cr | 45.8x | 5.5x | 11.7% | 11.9% | 0.00 | 5.8% | +7.1% | 0.00% |
| NUCLEUS Nucleus Software Exports Limited | 1,725 cr | 16.4x | 1.9x | 11.6% | 15.4% | 0.00 | 12.1% | -3.4% | 1.91% |
| SUBEXLTD Subex Limited | 969 cr | 31.9x | 2.8x | 8.7% | 9.2% | 0.00 | 10.3% | +19.6% | 0.00% |
| QUICKHEAL Quick Heal Technologies Limited | 730 cr | - | 1.7x | -2.5% | -4.7% | 0.00 | -4.3% | -21.4% | 0.00% |
| IRIS IRIS RegTech Solutions Limited | 420 cr | - | 2.1x | - | 8.6% | 0.00 | - | +9.7% | 0.00% |
| VIRINCHI Virinchi Limited | 144 cr | - | 0.3x | -5.4% | 1.4% | 0.29 | -9.5% | -12.0% | 0.00% |
| XELPMOC Xelpmoc Design And Tech Limited | 112 cr | - | 1.5x | - | -9.2% | 0.00 | - | +22.5% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from -180.2% to -194.6% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.